Legend Biotech (LEGN) Shares Outstanding (2020 - 2024)

Legend Biotech has reported Shares Outstanding for 5 years, with the latest figure at $367.3 million in Q4 2024.

• For the quarter ending Q4 2024, Shares Outstanding rose 0.96% year-over-year to $367.3 million; the trailing twelve-month figure through Dec 2024 stood at $367.3 million (up 0.96% YoY), and the FY2024 full-year result was $367.3 million, up 0.96% from the prior year.
• Shares Outstanding for Q4 2024 stood at $367.3 million, up from $363.8 million in the prior quarter.
• The five-year high for Shares Outstanding was $367.3 million in Q4 2024, with the low at $266.0 million in Q4 2020.
• Historically, Shares Outstanding has averaged $327.1 million across 5 years, with a median of $330.1 million in 2022.
• Annual changes were most pronounced in 2021 — Shares Outstanding climbed 15.96% — and 2024, when it rose 0.96%.
• Legend Biotech's Shares Outstanding stood at $266.0 million in 2020, then grew by 15.96% to $308.5 million in 2021, then gained by 7.03% to $330.1 million in 2022, then climbed by 10.2% to $363.8 million in 2023, then climbed by 0.96% to $367.3 million in 2024.
• The last three Shares Outstanding figures came in at $367.3 million (Q4 2024), $363.8 million (Q4 2023), and $330.1 million (Q4 2022), per Business Quant data.